Table 1.
Case Series of Patients Undergoing Laparoscopic Spleen-preserving Distal Pancreatectomy with Splenic Vessel Preservation
| # | Patient | BMI (kg/m2) | Indication for Surgery | Operative Time (Min) | EBL (mL) | Complication(s) | LOS (Days) | Final Pathology |
|---|---|---|---|---|---|---|---|---|
| 1 | 56F | 24 | MRI: ∼1 × 1 cm cystic lesion in the pancreatic tail CgA 19–9: 106.5 U/mL Cyst fluid CEA: 628.1 | 121 | 25 | N | 3 | 1.1 x 1.0 x 0.8 cm IPMN with minimal atypia. PanIN-1B |
| 2 | 18F | 21 | CT: 3.2 × 2.6 cm exophytic hypodense lesion in pancreatic body MRI: 3.2 × 3.4 x 2.4 cm mass | 199 | 25 | N | 5 | 4.0 x 2.1 x 2.0 cm solid pseudopapillary neoplasm |
| 3 | 69F | 32 | CT: 7 mm cystic lesion with upstream pancreatic ductal dilatation FNA: possible serous cyst, pancreatic intraepithelial neoplasia and intraductal mucinous neoplasm | 84 | 20 | N | 4 | 6.5 x 5.0 x 2.2 cm IPMN PanIN 1 and 2 |
| 4 | 68F | 43 | CT: pancreatic tail multicystic lesions | 111 | 25 | N | 12 | 6.0 x 3.0 x 1.0 cm IPMN with severe dysplasia PanIN 1A |
| 5 | 46F | 28 | CT: incidental 3.2 × 2.6 cm hyperenhancing pancreatic tail mass | 49 | 5 | N | 3 | 4.7 x 4.0 x 2.5 cm well-differentiated, low-grade PNET |
| 6 | 53M | 26 | CT: pancreatic tail partially cystic versus solid neoplasm CgA: 528 | 135 | 20 | N | 3 | 4.0 × 4.0 cm Lymphoepithelial cyst |
| 7 | 62M | 32 | CT: large right renal mass and pancreatic tail abnormality in the tip of the pancreas MRI: microcystic subcentimeter pancreatic tail lesion CEA: 3.9 | 238 | 100 | N | 3 | 0.7 x 0.5 x 0.4 cm unilocular serous cystic neoplasm. PanIN-1 AClear cell renal cell carcinoma |
MRI, magnetic resonance imaging; CT, computed tomography; CgA, chromogranin A; CEA, carcinoembryonic antigen; BMI, body mass index; EBL, estimated blood loss; LOS, length of stay; IPMN, intraductal papillary mucinous neoplasm; PanIN, pancreatic intraepithelial neoplasia: FNA, fine needle aspiration; PNET, primitive neuro-ectodermal tumors.